| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 01/31/2008 | US20080027062 2-amino-4-N-cyclohexylmethylamino-6-(L-erythro-1,2-dihydroxypropyl)-7,8-dihydro-pteridine; treatment of pathological blood pressure decreases, such as occur in septic or hemorrhagic shock, in tumor or cancer therapy with cytokines, liver cirrhosis; ulcerative colitis; NO synthase inhibitor |
| 01/31/2008 | US20080027051 Novel Heteroaryl Substituted Benzoxazoles |
| 01/31/2008 | US20080027049 Benzofurans as potassium ion channel modulators |
| 01/31/2008 | US20080027041 Pyridizinone derivatives |
| 01/31/2008 | US20080027036 S1P receptor modulating compounds and use thereof |
| 01/31/2008 | US20080027035 Dpp-Iv Inhibitors |
| 01/31/2008 | US20080027024 Dietary supplement and methods of use |
| 01/31/2008 | US20080027014 Novel SGLT inhibitors |
| 01/31/2008 | US20080026996 Selective Vpac2 Receptor Reptide Agonists |
| 01/31/2008 | US20080026084 Method and composition for management of weight and blood sugar |
| 01/31/2008 | US20080026070 Pharmaceutical formulations for the prolonged release of active principle(s), and their applications, especially therapeutic applications |
| 01/31/2008 | US20080026067 Method for Increasing Specific Surface Area of Slightly Soluble Drug |
| 01/31/2008 | US20080025986 Methods of Treating Tnf-Mediated Disorders |
| 01/31/2008 | US20080025952 Methods for targeted deliver of genetic material to the liver |
| 01/31/2008 | CA2659012A1 Methods of diagnosis and treatment for metabolic disorders |
| 01/31/2008 | CA2658951A1 Adult sertoli cells and uses thereof |
| 01/31/2008 | CA2658923A1 Substituted spiroketal derivatives and use thereof as therapeutic drug for diabetes |
| 01/31/2008 | CA2658921A1 Fused ring spiroketal derivative and use thereof as anti-diabetic drug |
| 01/31/2008 | CA2658654A1 Exendin fusion proteins |
| 01/31/2008 | CA2658625A1 Substituted imidazolone derivatives, preparation and uses |
| 01/31/2008 | CA2658204A1 Human artificial chromosome (hac) vector and human cell medicine comprising same |
| 01/31/2008 | CA2656716A1 N-(aminoheteroaryl)-1h-indole-2-carboxamide derivatives, and preparation and therapeutic application thereof |
| 01/30/2008 | EP1882686A2 Pyrrolidine and piperidine derivates as nk1 antagonists |
| 01/30/2008 | EP1882684A1 Pyrrolidine derivative or salt thereof |
| 01/30/2008 | EP1882475A1 Method of treating disorders mediated by the fibroblast growth factor receptor |
| 01/30/2008 | EP1882474A1 Prophylactic/therapeutic agent for abnormalities of sugar/lipid metabolism |
| 01/30/2008 | EP1882472A1 Drugs, food or drink for improving pancreatic functions |
| 01/30/2008 | EP1881961A1 New haloalkylsulfone substituted compounds useful for treating obesity and diabetes |
| 01/30/2008 | EP1881960A1 Novel specific caspase-10 inhibitors |
| 01/30/2008 | EP1881958A1 Diacylglycerol acyltransferase inhibitors |
| 01/30/2008 | EP1881850A1 Glp-1 pegylated compounds |
| 01/30/2008 | EP1881841A1 Compositions comprising tripeptides inhibiting ace |
| 01/30/2008 | EP1599477B1 Sulfonamide substituted xanthine derivatives for use as pepck inhibitors |
| 01/30/2008 | EP0941125B1 Methods for regulating angiogenesis |
| 01/30/2008 | CN101115763A Novel polyphenol glycoside derived from acerola |
| 01/30/2008 | CN101115741A 3,4-dihydro-1h-isoquinoline-2-carboxylic acid 5-aminopyridin-2-yl esters |
| 01/30/2008 | CN101115735A Glucagon receptor antagonists, preparation and therapeutic uses |
| 01/30/2008 | CN101115731A Oxadiazole derivatives as DGAT inhibitors |
| 01/30/2008 | CN101115726A Substituted piperazines as cb1 antagonists |
| 01/30/2008 | CN101115706A Methods of making pravastatin sodium |
| 01/30/2008 | CN101115491A Therapeutic agent |
| 01/30/2008 | CN101115483A Pharmaceutical composition containing fbpase-inhibiting agent |
| 01/30/2008 | CN101113982A Method for screen selecting polypeptides excitomotor of glucagon-like peptide-1 receptor in vitro |
| 01/30/2008 | CN101113149A Aliphatic organic acid salt of berberine type alkaloid and preparation method and usage thereof |
| 01/30/2008 | CN101112611A Chinese patent drug for treating diabetic impotency |
| 01/30/2008 | CN101112595A Chinese patent medicine for treating diabetic cardiac disease |
| 01/30/2008 | CN101112594A Chinese traditional medicine compounding for treating diabetes urinary tract infection |
| 01/30/2008 | CN101112593A Chinese traditional medicine composition for treating diabetic cardiac disease |
| 01/30/2008 | CN101112579A Diabetes treating medicine |
| 01/30/2008 | CN101112570A Chinese medicine preparation for treating diabetic aphtha |
| 01/30/2008 | CN101112557A Chinese traditional medicine composition for treating diabetic aphtha |
| 01/30/2008 | CN101112551A Composition comprising bamboo extract and the compounds isolated therefrom showing treating and preventing activity for inflammatory and blood circulation disease |
| 01/30/2008 | CN101112549A Chinese patent drug for treating diabetic hypertension |
| 01/30/2008 | CN101112545A Oral traditional Chinese medicine decoction for treating diabetes |
| 01/30/2008 | CN101112539A Chinese patent medicine for treating diabetic cerebral apoplexy |
| 01/30/2008 | CN101112538A Chinese traditional medicine preparations for treating diabetic hypertension |
| 01/30/2008 | CN101112534A Chinese traditional medicine compounding for treating diabetes retina pathological changes |
| 01/30/2008 | CN101112529A Function of sealwort and matrimony vine for treating hyperlipemia |
| 01/30/2008 | CN101112525A Health products having functions of invigorating qi and blood and restoring consciousness and refreshing oneself |
| 01/30/2008 | CN101112517A Chinese traditional medicine compounding for treating diabetic cardiac disease |
| 01/30/2008 | CN101112516A Chinese patent medicine for treating diabetic cardiac disease |
| 01/30/2008 | CN101112515A Chinese traditional medicine compounding for treating diabetic cardiac disease |
| 01/30/2008 | CN101112502A Chinese traditional medicine composition for treating diabetic cerebral apoplexy |
| 01/30/2008 | CN101112501A Chinese traditional medicine composition for treating diabetic hypertension |
| 01/30/2008 | CN101112500A Chinese traditional medicine composition for treating diabetes retina pathological changes |
| 01/30/2008 | CN101112492A Chinese traditional medicine preparations for treating diabetic hypertension |
| 01/30/2008 | CN101112475A Chinese traditional medicine composition for treating diabetes and the complication |
| 01/30/2008 | CN101112465A Maoyan' berry effervescence tablets and production process thereof |
| 01/30/2008 | CN101112460A Chinese traditional medicine compounding for treating diabetes retina lesions |
| 01/30/2008 | CN101112457A Health-care oral liquid for slimming, reducing fat, taking good care of skin, expelling toxin and strengthening stomach |
| 01/30/2008 | CN101112433A Chinese traditional medicine compounding for treating diabetic cerebral apoplexy |
| 01/30/2008 | CN101112421A Slimming capsule preparations |
| 01/30/2008 | CN101112410A Composition of indigo fruit, isoflavone and calcium |
| 01/30/2008 | CN101112408A Sustained-release ji chrysanthemum tablet and method for preparing the same |
| 01/30/2008 | CN101112400A oral liquid and capsule for preventing and curing various diseases |
| 01/30/2008 | CN101112385A Application of sodium thiosulfate in the preparation of clinical selenium-complementing and cancer-treating medicine and fast- preparing method for the same |
| 01/30/2008 | CN101112364A Hepadestal preparations and method for preparing the same |
| 01/30/2008 | CN101112359A Method for preparing transparent water-dispersible concentrated liquor of beta-carotin |
| 01/30/2008 | CN101112211A Antihyperglycemic milk and method for making the same |
| 01/30/2008 | CN101112191A Method for breeding health-care chook and the health-care chook thereof |
| 01/30/2008 | CN100365011C Process for producing asparagus saponin |
| 01/30/2008 | CN100364971C Pyrrolidine-2-ones as factor Xa inhibitors |
| 01/30/2008 | CN100364601C Chinese traditional medicine composition for treating diabetic nephropathy |
| 01/30/2008 | CN100364592C Medicine for treating diabetes |
| 01/30/2008 | CN100364584C Method for preparing compound micron pini-konnjaku juice fat-reducing sugar-reducing oral liquor |
| 01/30/2008 | CN100364579C Oral medicine for treating hyperlipemia |
| 01/30/2008 | CN100364570C Medicinal composition with blood sugar reducing action and its preparing method |
| 01/30/2008 | CN100364563C Combination for restraining p38 subfanmily of protein kinase activated by mitogen and application |
| 01/30/2008 | CN100364559C Method for preparing oral liquid of several micron powders for reducing blood sugar and anti-fatigue |
| 01/30/2008 | CN100364556C Application of H. seniavinii in preparation of weight-reducing food |
| 01/30/2008 | CN100364555C Application of H. seniavinii in preparation of food for resisting depression or/and promoting memory for learning |
| 01/30/2008 | CN100364553C Natural medicinal composition for preparing diabete drug |
| 01/30/2008 | CN100364552C Load type super-fine copper-powder copper-complementary agent, its prepn. method and use |
| 01/30/2008 | CN100364551C Load type super-fine zinc powder zinc-complementary agent, its prepn. method and use |
| 01/30/2008 | CN100364549C Load type super-fine iron powder iron-complementary agent, its prepn. method and use |
| 01/30/2008 | CN100364548C Iron replenisher with control released iron and its preparing method and use |
| 01/30/2008 | CN100364547C Load type molecular iodine complementary agent, and its prepn. method and use |
| 01/30/2008 | CN100364538C Application of fugillin in treating immunity entiritis and related immunity disease |
| 01/30/2008 | CN100364533C Pyrolidone hydrochloride drip pill and its preparation method |
| 01/30/2008 | CN100364532C Composition containing amlodipine and angiotensin II receptor inhibitor |